Cargando…
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
It has been almost 25 years since the initial discovery that tau was the primary component of the neurofibrillary tangles (NFTs) in Alzheimer disease (AD) brain. Although AD is defined by both β-amyloid (Aβ) pathology (Aβ plaques) and tau pathology (NFTs), whether or not tau played a critical role i...
Autores principales: | Pritchard, Susanne M, Dolan, Philip J, Vitkus, Alisa, Johnson, Gail VW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373356/ https://www.ncbi.nlm.nih.gov/pubmed/21348938 http://dx.doi.org/10.1111/j.1582-4934.2011.01273.x |
Ejemplares similares
-
Tau Clearance Mechanisms and Their Possible Role in the Pathogenesis of Alzheimer Disease
por: Chesser, Adrianne S., et al.
Publicado: (2013) -
Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52
por: Jo, Chulman, et al.
Publicado: (2014) -
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
por: Aillaud, Isabelle, et al.
Publicado: (2022) -
A T231E Mutant that Mimics Pathologic Phosphorylation of Tau in Alzheimer’s disease Causes Activation of the Mitochondrial Unfolded Protein Response in C. elegans touch neurons
por: Guha, Sanjib, et al.
Publicado: (2020) -
Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets
por: Pooler, Amy M, et al.
Publicado: (2013)